Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nivolumab”

1,510 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,510 results

Testing effectiveness (Phase 2)Study completedNCT02939300
What this trial is testing

Ipilimumab and Nivolumab in Leptomeningeal Metastases

Who this might be right for
Leptomeningeal Carcinomatosis
Massachusetts General Hospital 18
Testing effectiveness (Phase 2)Study completedNCT03647839
What this trial is testing

Modulation Of The Tumour Microenvironment Using Either Vascular Disrupting Agents or STAT3 Inhibition in Order to Synergise With PD1 Inhibition in Microsatellite Stable, Refractory Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
Australasian Gastro-Intestinal Trials Group 90
Testing effectiveness (Phase 2)Looking for participantsNCT03645928
What this trial is testing

Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors

Who this might be right for
Metastatic MelanomaSquamous Cell Carcinoma of the Head and NeckNon-small Cell Lung Cancer
Iovance Biotherapeutics, Inc. 245
Testing effectiveness (Phase 2)Study completedNCT04170556
What this trial is testing

Regorafenib Followed by Nivolumab in Patients With Hepatocellular Carcinoma (GOING)

Who this might be right for
Hepatocellular Carcinoma
Fundacion Clinic per a la Recerca Biomédica 69
Early research (Phase 1)Active Not RecruitingNCT03655002
What this trial is testing

IRX-2, Cyclophosphamide, and Nivolumab in Treating Patients With Recurrent or Metastatic and Refractory Liver Cancer

Who this might be right for
Recurrent Hepatocellular CarcinomaRefractory Liver CarcinomaStage IV Hepatocellular Carcinoma AJCC v8+2 more
City of Hope Medical Center 8
Not applicableStudy completedNCT03325257
What this trial is testing

Post-ATU Study of Nivolumab

Who this might be right for
Melanoma
Nantes University Hospital 350
Large-scale testing (Phase 3)Ended earlyNCT04458909
What this trial is testing

Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal Cancer

Who this might be right for
Metastatic Nasopharyngeal CarcinomaMetastatic Nasopharyngeal Keratinizing Squamous Cell CarcinomaMetastatic Nasopharyngeal Nonkeratinizing Carcinoma+8 more
National Cancer Institute (NCI) 15
Early research (Phase 1)Looking for participantsNCT04295863
What this trial is testing

Comparing Dosing Intervals of Nivolumab or Pembrolizumab in Locally Advanced or Metastatic Cancers

Who this might be right for
Metastatic Cancer
University of Chicago 264
Testing effectiveness (Phase 2)Ended earlyNCT02992964
What this trial is testing

Pilot Study of Nivolumab in Pediatric Patients With Hypermutant Cancers

Who this might be right for
Refractory or Recurrent Hypermutated MalignanciesBiallelic Mismatch Repair Deficiency (bMMRD) Positive Patients
The Hospital for Sick Children 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT03233152
What this trial is testing

A Phase I/II Clinical Trial on the Per-operative Intratumoral Administration of Myeloid Dendritic Cells Plus Ipilimumab and Nivolumab, Followed by Repeated Intracavitary Plus Intravenous Administration of Nivolumab in Patients With Recurrent Glioblastoma.

Who this might be right for
Glioblastoma
Universitair Ziekenhuis Brussel 110
Not applicableStudy completedNCT06361563
What this trial is testing

Real-World Use of Adjuvant Nivolumab in Patients With Upper Gastrointestinal Cancer in Canada

Who this might be right for
Upper Gastrointestinal Cancer
Bristol-Myers Squibb 250
Large-scale testing (Phase 3)Active Not RecruitingNCT02224781
What this trial is testing

Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Melanoma+2 more
National Cancer Institute (NCI) 267
Testing effectiveness (Phase 2)UnknownNCT03048500
What this trial is testing

Nivolumab and Metformin Hydrochloride in Treating Patients With Stage III-IV Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage III Non-Small Cell Lung CancerStage IIIA Non-Small Cell Lung Cancer+2 more
Northwestern University 17
Testing effectiveness (Phase 2)Study completedNCT04072198
What this trial is testing

Nivolumab Plus FOLFOXIRI/Bevacizumab in First Line Chemotherapy of Advanced Colorectal Cancer RASm/BRAFm Patients

Who this might be right for
Colorectal Cancer
Gruppo Oncologico Italiano di Ricerca Clinica 73
Testing effectiveness (Phase 2)Active Not RecruitingNCT04457284
What this trial is testing

Temozolomide, Cisplatin, and Nivolumab in People With Colorectal Cancer

Who this might be right for
Colorectal Adenocarcinoma
Memorial Sloan Kettering Cancer Center 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT04195139
What this trial is testing

Nivolumab and Temozolomide Versus Temozolomide Alone in Newly Diagnosed Elderly Patients With GBM

Who this might be right for
Glioblastoma Multiforme
University of Sydney 103
Testing effectiveness (Phase 2)Study completedNCT01714739
What this trial is testing

An Anti-KIR Antibody Lirilumab in Combination With an Anti-PD1 Antibody Nivolumab and Nivolumab Plus an Anti-CTLA-4 Ipilimumab Antibody in Patients With Advanced Solid Tumors

Who this might be right for
CANCER,NOS
Bristol-Myers Squibb 337
Testing effectiveness (Phase 2)Looking for participantsNCT04984733
What this trial is testing

Temozolomide + Nivolumab in MGMT Methylated Oesophagogastric Cancer

Who this might be right for
Adenocarcinoma - GEJCancer of Esophagus
University of Southampton 18
Testing effectiveness (Phase 2)Study completedNCT02243371
What this trial is testing

GVAX Pancreas Vaccine (With CY) and CRS-207 With or Without Nivolumab

Who this might be right for
Previously Treated Metastatic Adenocarcinoma of the Pancreas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 93
Testing effectiveness (Phase 2)Study completedNCT02434081
What this trial is testing

NIvolumab COmbination With Standard First-line Chemotherapy and Radiotherapy in Locally Advanced Stage IIIA/B Non-Small Cell Lung Carcinoma

Who this might be right for
Non-small Cell Lung Cancer Stage III
ETOP IBCSG Partners Foundation 94
Load More Results